Group | Chemical | Abbreviation | CAS no. | In vivo MN assay (Liver) | Rat carcinogenicity | |||||
---|---|---|---|---|---|---|---|---|---|---|
2 weeks | Ref. | 4 weeks | Ref. | Liver | Other sites | Ref. | ||||
Group A | Dimethylnitrosamine | DMN | 62–75-9 | + | [2] | + | [2] | + | kid, lun, vsc, tes | [22] |
N-Nitrosopyrrolidine | NPYR | 930–55-2 | + | [2] | + | [2] | + | kid, vsc, tes | ||
4,4′-Methylenedianiline | MDA | 101–77-9 | + | [2] | + | [2] | + | thy | [24] | |
N-Nitrosodipropylamine | NDPA | 621–64-7 | + | [2] | ND | + | eso, nas | [22] | ||
2,4-Dinitrotoluene | 2,4-DNT | 121–14-2 | + | [2] | + | [2] | + | ski, mgl | [22] | |
2,6-Dinitrotoluene | 2,6-DNT | 606–20-2 | + | [2] | + | [2] | + | – | [22] | |
Quinoline | QUN | 91–22-5 | + | [2] | + | [2] | + | – | [25] | |
p-Dimethylaminoazobenzene | DAB | 60–11-7 | + | [2] | + | [2] | + | – | [22] | |
2-Nitropropane | 2-NP | 79–46-9 | + | [2] | + | [2] | + | – | [26] | |
Monocrotaline | MCT | 315–22-0 | + | [2] | + | [2] | + | – | [22] | |
N-Nitrosomorpholine | NMOR | 59–89-2 | + | [2] | ND | + | vsc | [22] | ||
2-Acetylaminofluorene | 2-AAF | 53–96-3 | + | [2] | + | [2] | + | ski, mgl | [22] | |
Sudan I (C.I.solvent yellow 14) | Sudan I | 842–07-9 | + | [21] | ND | + | – | [22] | ||
Thioacetamide | TAA | 62–55-5 | + | [21] | + | [21] | + | – | [22] | |
Group B | Mitomycin C | MMC | 50–07-7 | + | [2] | + | [2] | – | per | [22] |
Cyclophosphamide H2O | CP | 6055-19-2 | – | [2] | ND | – | ub, lym, ner | [27] | ||
Potassium bromate | KBrO3 | 7758-01-2 | – | [2] | – | [2] | – | kid, per, thy | [22] | |
N-Methyl-N′-nitro-N-nitrosoguanidine | MNNG | 70–25-7 | – | [2] | – | [2] | – | eso, smi, sto | [22] | |
Methyl methanesulfonate | MMS | 66–27-3 | + | [2] | – | [2] | – | hmo, lun, ner | ||
Kojic acid | KA | 501–30-4 | – | [2] | – | [2] | – | thy (mouse) | [22] |